Viewing Study NCT00220402


Ignite Creation Date: 2025-12-25 @ 3:56 AM
Ignite Modification Date: 2026-04-06 @ 9:57 PM
Study NCT ID: NCT00220402
Status: COMPLETED
Last Update Posted: 2008-11-24
First Post: 2005-08-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Long-Term Open-Label Extension Trial for Subjects Completing the Phase 3 Trial of Fesoterodine (SP583) for the Treatment of Overactive Bladder Syndrome
Sponsor: Pfizer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module